My Personal Biomedical Research Feed – Ralph Turchiano, CEO Alchepharma
Public release date: 31-Aug-2010 - will plead guilty to one misdemeanor charge of “misbranding,” - Allergan “paid kickbacks to induce physicals to inject Botox for off-label uses [caption id="" align="aligncenter"…
2010 report posted for filing Botox maker to pay $600M to resolve investigation By MATTHEW PERRONE, AP Health Writer Matthew Perrone, Ap Health Writer Thu Sep 2,…
Contact: Sumrina Yousufzai syousufzai@plos.org 415-568-3164 Public Library of Science COI declarations and off-label drug use Conflict-of-interest statements made by physicians and scientists in their medical journal articles after they had…
Public release date: 2-Aug-2012 Dangerous experiment in fetal engineering Risky prenatal use of steroid to try to prevent intersex, tomboys and lesbians CHICAGO --- A new paper just published in…
Public release date: 16-Jun-2009 - was done despite Lilly’s access and knowledge of at least seven studies that showed the drug was apparently ineffective for the treatment of dementia -…
Public release date: 24-Nov-2008 - quetiapine (brand name Seroquel), warfarin, escitalopram, risperidone and montelukast etc... STANFORD, Calif. — Physicians and policy-makers know that drugs are frequently prescribed to treat…
Public release date: 27-Oct-2008 Off-label prescription of a drug is generally legal, but promotion of off-label uses by a drug manufacturer is illegal. In an article in this week's PLoS Medicine,…
You must be logged in to post a comment.